Table 1.
Treatment group | Person-time of observation (years) | No of deaths | Mortality ratio (95% CI)
|
|
---|---|---|---|---|
Adjusted for age and sex | Full adjustment* | |||
Levodopa alone | 9028.0 | 1124 | 1.00 | 1.00 |
Selegiline alone | 1118.3 | 136 | 1.13 (0.95 to 1.35) | 1.14 (0.95 to 1.36) |
Selegiline with levodopa | 4102.0 | 460 | 1.12 (1.00 to 1.25) | 1.10 (0.98 to 1.23) |
Selegiline alone or with levodopa | 5220.3 | 596 | 1.12 (1.01 to 1.24) | 1.11 (1.00 to 1.23) |
Adjusted for age, sex, calendar year, smoking habit, regional health authority, diagnosis group, use of antidepressants (and specifically tricyclics and serotonin reuptake inhibitors), history of cerebrovascular disease, history of ischaemic heart disease, and incident or prevalent disease at entry to study.